Plunkett Research Online: Sigilon Therapeutics Inc

SIGILON THERAPEUTICS INC (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Sigilon Therapeutics Inc is a clinical stage biopharmaceutical company. The company is developing a new class of therapeutics and functional cures for patients with chronic diseases by providing stable and durable levels of therapeutic molecules to patients. Its lead product candidate, SIG-001, prev.....


SIGILON THERAPEUTICS INC

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 617 336-7540
Fax:
Address: 100 Binney Street
Cambridge, MA 2142 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: Eli Lilly & Co

Contacts Description

Sigilon Therapeutics Inc is a clinical stage biopharmaceutical company. The company is developing a new class of therapeutics and functional cures for patients with chronic diseases by providing stable and durable levels of therapeutic molecules to patients. Its lead product candidate, SIG-001, prev.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture